Presenting Health Economic

Evaluation Results

Didik Setiawan, PhD., Apt

- Faculty of Pharmacy,
- Center for Health Economic Studies,
Universitas Muhammadiyah Purwokerto, Purwokerto, Indonesia
Health Technology Assessment

• Technology
• The practical application of knowledge
• Health Technology
• The practical application of knowledge to improve or maintain individual
and population health
Properties and Impacts Assessed

• Technical properties
• Safety
• Efficacy and/or effectiveness
• Economic attributes or impacts
• Social, legal, ethical and/or political impacts
Pharmacoeconomic study presentation

No p value needed
Incremental Cost Effectiveness Ratio

• The nature of health economic is comparing at least two health

technologies.

&' (&)
• 𝐼𝐶𝐸𝑅 =
*' (*)

• Consider apple to apple comparison.

• ACER (C/E) is not recommended
Cost Effectiveness Threshold/Willingness-to-
pay/Ceiling ratio

Country Cost Effectiveness Threshold/Willingness-

to-pay/Ceiling ratio
United Kingdom £20,000 – £30,000
Kanada CA$20,000 – CA$100,000
Amerika US$50,000 – US$ 100,000
Belanda €20,000 - €80,000
Thailand THB120,000 – THB130,000

WHO* <3x Produk Domestik Bruto

Univariate Sensitivity Analysis (Tornado Diagram)
Probabilistic Sensitivity Analysis

20000000

18000000

16000000

14000000
Incremental cost

12000000

10000000

8000000

6000000

4000000

2000000

0
0 500 1000 1500 2000 2500 3000
Incremental QALYs
Cost Effectiveness Acceptibility Curve (CEAC)

0.8
Proporsi cost-effective

0.6

0.4

0.2

0
0 5000 10000 15000 20000 25000 30000
Willingness to Pay
Didik Setiawan, PhD., Apt

Email: d.didiksetiawan@gmail.com
WA: +31 631 254575
Phone: 081 226 700 119
www.ches.ump.ac.id